These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 33232477)

  • 21. Role of PAR2 in murine pulmonary pseudomonal infection.
    Moraes TJ; Martin R; Plumb JD; Vachon E; Cameron CM; Danesh A; Kelvin DJ; Ruf W; Downey GP
    Am J Physiol Lung Cell Mol Physiol; 2008 Feb; 294(2):L368-77. PubMed ID: 18083764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protease-activated receptor 2 does not contribute to renal inflammation or fibrosis in the obstructed kidney.
    Ma FY; Han Y; Ozols E; Chew P; Vesey DA; Gobe GC; Morais C; Lohman RJ; Suen JY; Johnson DW; Fairlie DP; Nikolic-Paterson DJ
    Nephrology (Carlton); 2019 Sep; 24(9):983-991. PubMed ID: 31314137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Critical requirement of VEGF-C in transition to fetal erythropoiesis.
    Fang S; Nurmi H; Heinolainen K; Chen S; Salminen E; Saharinen P; Mikkola HK; Alitalo K
    Blood; 2016 Aug; 128(5):710-20. PubMed ID: 27343251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neutrophil activation by the tissue factor/Factor VIIa/PAR2 axis mediates fetal death in a mouse model of antiphospholipid syndrome.
    Redecha P; Franzke CW; Ruf W; Mackman N; Girardi G
    J Clin Invest; 2008 Oct; 118(10):3453-61. PubMed ID: 18802482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronological expression of PAR isoforms in acute liver injury and its amelioration by PAR2 blockade in a rat model of sepsis.
    Jesmin S; Gando S; Zaedi S; Sakuraya F
    Thromb Haemost; 2006 Dec; 96(6):830-8. PubMed ID: 17139380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MEK kinase 1 activity is required for definitive erythropoiesis in the mouse fetal liver.
    Bonnesen B; Orskov C; Rasmussen S; Holst PJ; Christensen JP; Eriksen KW; Qvortrup K; Odum N; Labuda T
    Blood; 2005 Nov; 106(10):3396-404. PubMed ID: 16081685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of the blood island during normal and 5-fluorouracil-perturbed hemopoiesis.
    Vogt C; Noé G; Rich IN
    Blood Cells; 1991; 17(1):105-21; discussion 121-5. PubMed ID: 2018848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of protease-activated receptor 2 in regulation of renin synthesis and secretion in mice.
    Thurner LR; Höcherl K
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Nov; 392(11):1401-1410. PubMed ID: 31243492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nrf2 deficiency in mice attenuates erythropoietic stress-related macrophage hypercellularity.
    Gbotosho OT; Kapetanaki MG; Ross M; Ghosh S; Weidert F; Bullock GC; Watkins S; Ofori-Acquah SF; Kato GJ
    Exp Hematol; 2020 Apr; 84():19-28.e4. PubMed ID: 32151553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual blockade of protease-activated receptor 1 and 2 additively ameliorates diabetic kidney disease.
    Mitsui S; Oe Y; Sekimoto A; Sato E; Hashizume Y; Yamakage S; Kumakura S; Sato H; Ito S; Takahashi N
    Am J Physiol Renal Physiol; 2020 May; 318(5):F1067-F1073. PubMed ID: 32200667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Defective fetal liver erythropoiesis and T lymphopoiesis in mice lacking the phosphatidylserine receptor.
    Kunisaki Y; Masuko S; Noda M; Inayoshi A; Sanui T; Harada M; Sasazuki T; Fukui Y
    Blood; 2004 May; 103(9):3362-4. PubMed ID: 14715629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A T cell-specific knockout reveals an important role for protease-activated receptor 2 in lymphocyte development.
    Francis N; Every AL; Ayodele BA; Pike RN; Mackie EJ; Pagel CN
    Int J Biochem Cell Biol; 2017 Nov; 92():95-103. PubMed ID: 28951199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hematopoietic tissue factor-protease-activated receptor 2 signaling promotes hepatic inflammation and contributes to pathways of gluconeogenesis and steatosis in obese mice.
    Wang J; Chakrabarty S; Bui Q; Ruf W; Samad F
    Am J Pathol; 2015 Feb; 185(2):524-35. PubMed ID: 25476527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glomerular Injury Is Exacerbated in Lupus-Prone MRL/lpr Mice Treated with a Protease-Activated Receptor 2 Antagonist.
    Itto R; Oe Y; Imaruoka K; Sato E; Sekimoto A; Yamakage S; Kumakura S; Sato H; Ito S; Takahashi N
    Tohoku J Exp Med; 2019 Oct; 249(2):127-133. PubMed ID: 31666446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involvement of neutrophil recruitment and protease-activated receptor 2 activation in the induction of IL-18 in mice.
    Ikawa K; Nishioka T; Yu Z; Sugawara Y; Kawagoe J; Takizawa T; Primo V; Nikolic B; Kuroishi T; Sasano T; Shimauchi H; Takada H; Endo Y; Sugawara S
    J Leukoc Biol; 2005 Nov; 78(5):1118-26. PubMed ID: 16260585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protease-activated receptor 2 signaling in inflammation.
    Rothmeier AS; Ruf W
    Semin Immunopathol; 2012 Jan; 34(1):133-49. PubMed ID: 21971685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deletion of a flippase subunit
    Yang F; Huang Y; Chen X; Liu L; Liao D; Zhang H; Huang G; Liu W; Zhu X; Wang W; Lobo CA; Yazdanbakhsh K; An X; Ju Z
    Haematologica; 2019 Oct; 104(10):1984-1994. PubMed ID: 30819915
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells.
    Morris DR; Ding Y; Ricks TK; Gullapalli A; Wolfe BL; Trejo J
    Cancer Res; 2006 Jan; 66(1):307-14. PubMed ID: 16397244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential expression and regulation of protease-activated receptors in human peripheral monocytes and monocyte-derived antigen-presenting cells.
    Colognato R; Slupsky JR; Jendrach M; Burysek L; Syrovets T; Simmet T
    Blood; 2003 Oct; 102(7):2645-52. PubMed ID: 12805069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cooperation of tissue factor cytoplasmic domain and PAR2 signaling in breast cancer development.
    Schaffner F; Versteeg HH; Schillert A; Yokota N; Petersen LC; Mueller BM; Ruf W
    Blood; 2010 Dec; 116(26):6106-13. PubMed ID: 20861457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.